Yuqiang Wang

Yuqiang Wang

Company: Magpie Pharmaceuticals

Job title: Founder and CEO


Novel Multi-functional Small Molecule TBN Proves Promising in ALS Phase II Trial 2:10 pm

Optimizing recruitment strategy to achieve a significantly large phase 2 cohort of Chinese patients Outlining the observed effects on grip strength and other key markers of ALS progression Advancing TBN into a phase 3 study in ChinaRead more

day: Day Two Track B PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.